𝔖 Bobbio Scriptorium
✦   LIBER   ✦

p28GANK is a novel marker for prognosis and therapeutic target in gastric cancer

✍ Scribed by Zheng, J. -Y.; Hu, H.; Du, J. -J.; Li, X. -H.; Zhao, Q. -C.

Book ID
121541506
Publisher
SP MAIK Nauka/Interperiodica
Year
2014
Tongue
English
Weight
279 KB
Volume
48
Category
Article
ISSN
0026-8933

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

SCRN1 is a novel marker for prognosis in
SCRN1 is a novel marker for prognosis in colorectal cancer
✍ Norikatsu Miyoshi; Hideshi Ishii; Koshi Mimori; Mitsugu Sekimoto; Yuichiro Doki; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Abstract ## Purpose Secernin 1 (__SCRN1__) is a member of the secernin family and is reported to be a tumor‐associated antigen. Previous reports show that __SCRN1__ is upregulated in gastric cancer cell lines and may be a novel immunotherapy target, whereas its significance in colorectal cancer